Detalhe da pesquisa
1.
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Nat Immunol
; 22(12): 1503-1514, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716452
2.
Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition.
Immunity
; 55(11): 2135-2148.e6, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36306784
3.
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
J Virol
; 97(7): e0159622, 2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37395646
4.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470866
5.
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding.
Nat Commun
; 15(1): 3924, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38724518
6.
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
Nat Commun
; 15(1): 200, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172512
7.
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.
Structure
; 32(2): 131-147.e7, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157856
8.
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques.
Cell Rep Med
; 4(4): 101018, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023746
9.
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity.
Nat Commun
; 14(1): 580, 2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737435
10.
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN.
Sci Adv
; 8(47): eade4433, 2022 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36417525
11.
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates.
Sci Transl Med
; 14(632): eabi5735, 2022 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914540
12.
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model.
Vaccines (Basel)
; 10(5)2022 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35632473
13.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
bioRxiv
; 2021 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851155
14.
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
Cell Rep
; 37(12): 110143, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919799
15.
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters.
bioRxiv
; 2021 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159328
16.
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
bioRxiv
; 2021 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34013273
17.
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates.
bioRxiv
; 2021 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791694
18.
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.
NPJ Vaccines
; 6(1): 129, 2021 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711815
19.
A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein.
bioRxiv
; 2020 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32511298